These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3514469)

  • 21. A comparative study of the sensitivity of bacteria of various origin to ofloxacin.
    Gubina M
    Chemioterapia; 1987 Apr; 6(2):79-81. PubMed ID: 3474082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral ofloxacin for infections caused by bacteria resistant to oral antimicrobial agents.
    Eron LJ; Gentry LO
    Diagn Microbiol Infect Dis; 1992 Jul; 15(5):435-9. PubMed ID: 1643820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibacterial activities of ofloxacin against recent isolates from patients with community-acquired infections].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
    Jpn J Antibiot; 1991 Sep; 44(9):941-57. PubMed ID: 1960856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo antibacterial activity of disodium -sulfobenzylpenicillin.
    Yamazaki T; Tsuchiya K
    J Antibiot (Tokyo); 1971 Sep; 24(9):620-5. PubMed ID: 4399861
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative.
    Hirai K; Aoyama H; Hosaka M; Oomori Y; Niwata Y; Suzue S; Irikura T
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1059-66. PubMed ID: 2942103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A clinical and laboratory study of doxycycline ('Vibramycin'): a broad-spectrum antibiotic.
    Michalopoulos A
    Curr Med Res Opin; 1973; 1(8):445-55. PubMed ID: 4589631
    [No Abstract]   [Full Text] [Related]  

  • 28. [Summarized results of clinical phase II and III studies with ofloxacin (HOE 280) in Europe].
    Blomer R; Bruch K; Zahlten RN
    Infection; 1986; 14 Suppl 1():S102-7. PubMed ID: 3514468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1992). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Nov; 48(11):1627-57. PubMed ID: 8558754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1993). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H
    Jpn J Antibiot; 1995 Nov; 48(11):1757-87. PubMed ID: 8558757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys.
    Harding GK; Ronald AR; Boutros P; Lank B
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):9-12. PubMed ID: 1093658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Asymptomatic bacteriuria and symptomatic urinary tract infections (UTI) in patients with diabetes mellitus in Tikur Anbessa Specialized University Hospital, Addis Ababa, Ethiopia.
    Yeshitela B; Gebre-Selassie S; Feleke Y
    Ethiop Med J; 2012 Jul; 50(3):239-49. PubMed ID: 23409407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Spectrum of pathogens and resistance to antibiotics in urinary tract infections and the consequences for antibiotic treatment: study of urology inpatients with urinary tract infections (1994-2001)].
    Wagenlehner E; Niemetz A; Naber G
    Urologe A; 2003 Jan; 42(1):13-25. PubMed ID: 12574879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of ofloxacin treatment of experimental urinary tract infections].
    Ritzerfeld W
    Infection; 1986; 14 Suppl 1():S45-6. PubMed ID: 3514471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative in vitro activities of norfloxacin (MK-0366) and six commonly used antimicrobial agents against 199 urinary isolates showing various degrees of antibiotic resistance.
    Corigliano BE; Appleman MD; Heseltine PN; Leedom JM
    Diagn Microbiol Infect Dis; 1984 Apr; 2(2):101-6. PubMed ID: 6232085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experiences with trimethoprim-sulfamethoxazole in the chemotherapy of bacterial infections].
    Tauchnitz C
    Z Gesamte Inn Med; 1970 Aug; 25(16):734-8. PubMed ID: 4941224
    [No Abstract]   [Full Text] [Related]  

  • 37. Antibacterial activity of ofloxacin and its mode of action.
    Sato K; Inoue Y; Fujii T; Aoyama H; Mitsuhashi S
    Infection; 1986; 14 Suppl 4():S226-30. PubMed ID: 3028966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods.
    Klastersky J; Cappel R; Daneau D
    Cancer; 1973 Feb; 31(2):331-6. PubMed ID: 4569296
    [No Abstract]   [Full Text] [Related]  

  • 39. [The role of ampicillin in antibiotic therapy with special reference to laboratory findings].
    Legler F
    Arzneimittelforschung; 1966 Jul; 16(7):814-8. PubMed ID: 4870009
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cefazolin. 3. Double blind controlled trial in urinary tract infections].
    Seika K; Minakawa M; Miyoshi K; Yamaji K; Sugiyama Y
    Jpn J Antibiot; 1972 Apr; 25(2):72-8. PubMed ID: 4627212
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.